Mimicking H3 Substrate Arginine in the Design of G9a Lysine Methyltransferase Inhibitors for Cancer Therapy: A Computational Study for Structure-Based Drug Design

[Image: see text] G9a protein methyltransferase is a potential epigenetic drug target in different cancers and other disease conditions overexpressing the enzyme. G9a is responsible for the H3K9 dimethylation mark, which epigenetically regulates gene expression. Arg8 and Lys9 of the H3 substrate pep...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandar Charles, M. Ramya, Li, Mu-Chun, Hsieh, Hsing-Pang, Coumar, Mohane Selvaraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948220/
https://www.ncbi.nlm.nih.gov/pubmed/33718701
http://dx.doi.org/10.1021/acsomega.0c04710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948220/
https://www.ncbi.nlm.nih.gov/pubmed/33718701
http://dx.doi.org/10.1021/acsomega.0c04710

Ejemplares similares